TORN

Torrent Pharmaceuticals Limited

TORNTPHARM.NS·NSE

FollowCompareShare

4,545.00−13.90 (−0.30%)today

As of Oct 19, 1:44 PM IST · May be delayed up to 15 min · INR

1D5D1M6MYTD1Y5Y10Y20YAll

MountainLineCandles

Indicators

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close4,558.90

Open4,551.20

Day range4,532.404,618.70

52-week range3,532.605,250.00

Off day high−1.60%

Off 52-week high−13.43%

Volume139.08K

Avg. volume (3M)392.18K

Market cap1.73T

EPS (TTM)62.60

Forward P/E48.72

P/E ratio (TTM)72.60

Dividend yield0.83% (38.00)

Beta (5Y)—

Shares outstanding380.37M

Short interest—

Earnings dateJul 30, 2026 (est.)

Analyst target—

Profit margin—

Related companies

No related companies yet: the instruments index has no profile for TORRENT PHARMACEUTICALS L.

Latest news

All TORNTPHARM.NS news ›

mint·1d agoPositive

Who is Amal Kelshikar? Why did he resign from the position of Torrent Pharmaceuticals' Executive Director? Explained

Torrent Pharmaceuticals has accepted the resignation of its Executive Director, Amal Kelshikar. His resignation became effective from 16 October, 2026, at the close of business hours. The filing was made under Regulation 30 of SEBI Listing…

Kalkine India·2d agoPositive

Torrent Pharmaceuticals TORNTPHARM Executive Director Resignation

Torrent Pharmaceuticals (NSE:TORNTPHARM): Who Has Resigned as Executive Director? Kalkine India Torrent Pharmaceuticals (NSE:TORNTPHARM): Who Has Resigned as Executive Director? Source: Krish Capital Pty Ltd Torrent Pharmaceuticals Limited…

scanx.trade·2d ago

Torrent Pharmaceuticals accepts resignation of Executive Director Amal Kelshikar

Torrent Pharmaceuticals Limited accepted the resignation of Amal Kelshikar, Executive Director and Senior Management Personnel (SMP), effective from the close of business hours on October 16, 2026. The company informed BSE and NSE under…

Kalkine India·Oct 9Positive

Torrent Pharmaceuticals TORNTPHARM Analyst Call Oct 2026

Kalkine India Torrent Pharmaceuticals (NSE:TORNTPHARM): What Is the October 2026 Analyst Call About? Source: Krish Capital Pty Ltd Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) filed an exchange notice on 9th October 2026 informing…

From articles in the 4Search news index.

In the news

4mentions in 30 days

4with it in the headline

Positivesentiment

Mentioned with

Duopharma Biotech Berhad3Leading Tata Sons2Remuneration Committee2Tata Group2Tata Sons2Tata Sons Board2Abbott Laboratories1Abbvie Inc.1

People in the coverage

Datuk Wira Arham Bin Abdul Rahman3Hasnita Binti Hashim3Chintan M. Trivedi2Encik Mohamad Idros Bin Mosin2Gautam Doshi2John Militello2

Themes

Biotechnology3Corporate Governance3SEC Filings3Biotech2Director Resignation2Healthcare2Malaysia2N Chandrasekaran Resignation2

Most coverage from

1. kalkine.co.in2
2. livemint.com1
3. scanx.trade1

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 4 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.